Home/Filings/4/0001127602-10-012250
4//SEC Filing

Flanagan Thomas James 4

Accession 0001127602-10-012250

CIK 0000318154other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 3:22 PM ET

Size

7.9 KB

Accession

0001127602-10-012250

Insider Transaction Report

Form 4
Period: 2010-04-26
Transactions
  • Award

    Nqso (Right to Buy)

    2010-04-26$58.43/sh+40,000$2,337,20040,000 total
    Exercise: $58.43From: 2011-04-26Exp: 2020-04-26Common Stock (40,000 underlying)
  • Award

    Common Stock

    2010-04-26+5,80055,714 total
Footnotes (3)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest in four equal annual installments of 25% each commencing April 26, 2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 25,000 RSUs which fully vest on 7/31/2010; 8,500 RSUs which vest in three equal installments of 2,850 each commencing on 4/29/2010; 5,700 RSUs which vest in four equaly annual installments of 1,425 each commencing on 4/28/2010; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing no 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These options are exercisable in four equal annual installments of 25% each commencing 04/26/2011.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001376155

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 3:22 PM ET
Size
7.9 KB